Drugs/Recall·openFDA/drug

Safecor Health, LLC — Class II: Fluphenazine HCl Elixir, USP, 10 mg per 2 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 1

MediumPublished Sep 23, 2026· AI-analyzed Sep 29, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Safecor Health, LLC has initiated a Class II recall for Fluphenazine HCl Elixir, USP (10 mg per 2 mL) due to failure to meet stability specifications. The recall affects the 10 mL delivery volume packaged by the firm's Woburn, MA facility.

Who it affects

This recall affects Safecor Health, LLC, pharmacy distributors, and healthcare providers utilizing unit-dose fluphenazine HCl elixir (NDC 00121-0653-04). Clinical and pharmacy staff responsible for medication dispensing are also impacted.

Why it matters

A Class II recall indicates that the product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. The failure to meet stability specifications suggests potential issues with active ingredient potency or degradant levels over time, which may necessitate an investigation into the packaging process or the bulk product's stability profile under specific storage conditions.

Practical takeaway

Review current inventory for NDC 00121-0653-04 and segregate affected units. Quality teams should evaluate stability testing protocols and storage conditions for fluphenazine elixirs to ensure ongoing compliance with USP specifications throughout the product shelf life.

FDA source material

Class II. Reason: Failed Stability Specifications. Product: Fluphenazine HCl Elixir, USP, 10 mg per 2 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0653-04. Firm: Safecor Health, LLC (Woburn MA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.